Gerresheimer AG sets up new sales office in Moscow

- Representative office in Moscow opened - New support base intensifies marketing and sales - Russia's pharma market growing dynamically

Gerresheimer AG has set up a sales office in Moscow. The new representation centre will intensify the Group's business in pharmaceutical primary packaging and drug-delivery systems. "This is a strategically important step to further develop the fast-growing pharma & healthcare markets of Russia and neighboring regions," says Gerresheimer CEO Dr. Axel Herberg.

The Duesseldorf Group, which has been active in Russia for many years, has numerous customers there. For example the Group supplies the Moscow company Petrovax Pharm with large quantities of pre-sterilized RTF(R) (Ready To Fill) syringes for vaccines. The business in high-quality pharma vials and ampoules is also well established.

Regional representation will contribute to intensification not only of sales operations but also customer advice and technical service on the spot. In general, the Russian pharma industry has a strong interest in developing its quality and technologies together with competent partners.

This fast-growing pharma & healthcare market is seen as extremely dynamic and offers Gerresheimer good growth opportunities.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Healing with Artificial Intelligence highlights the future of patient care